Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/18/2010CN101805762A Purpose of separating arabinose through candida tropicalis fermentation and pharmaceutical and health care purposes of high-purity arabinose separation product
08/18/2010CN101805750A Construction and application of farnesyl pyrophosphoric acid synthetase RNA (Ribonucleic Acid) interference recombinant lentivirus vector
08/18/2010CN101805410A Technological method for comprehensively producing pueraria flavonid, puerarin and arrowroot starch
08/18/2010CN101805389A Preparation method of corosolic acid
08/18/2010CN101805377A Method for preparing D-mannose and mannan oligosaccharide by using banana root bulb dry powder
08/18/2010CN101805358A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in treatment of type 2 diabetes
08/18/2010CN101805337A Compound containing proline and isoxazole skeleton and preparation method and application thereof
08/18/2010CN101805336A Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof
08/18/2010CN101805325A Novel lignan compound and application thereof
08/18/2010CN101805308A Compound containing tyrosine and isoxazole skeleton and preparation method and application thereof
08/18/2010CN101805299A Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
08/18/2010CN101805298A Novel aryl- and heteroarylpiperazines
08/18/2010CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof
08/18/2010CN101804196A Soybean-based whole protein type enteral nutrition powder and preparation method thereof
08/18/2010CN101804170A Traditional Chinese medicine composition for treating hyperglycemia and preparation method thereof
08/18/2010CN101804145A Garlic oil enteric pellet capsule and preparation method thereof
08/18/2010CN101804144A Visceral fat accumulation inhibitor
08/18/2010CN101804141A Chinese medicine compound for preventing and curing hypertension, hyperlipidemia, hyperglycemia and complications thereof
08/18/2010CN101804137A Chinese medicine film preparation used in plasma filtering device
08/18/2010CN101804122A Tomato water-soluble saponin extract and preparation method and application thereof
08/18/2010CN101804110A Traditional Chinese medicine preparation for purifying blood
08/18/2010CN101804089A Use of total flavonoids from radix Daphne genkwa in preparing weight-losing hypolipemic drugs
08/18/2010CN101804081A Biological disinfectant and application thereof
08/18/2010CN101804077A Pretreatment method of propolis effective component raw material by supercritical extraction
08/18/2010CN101804068A Polyethylene glycol-electrolyte oral solution
08/18/2010CN101804056A Compound tablet of pioglitazone hydrochloride, glimepiride and preparation method thereof
08/18/2010CN101804055A Compound medicinal preparation
08/18/2010CN101804054A Application, preparation and preparation method of synthetic palmatine
08/18/2010CN101804045A 葛根素的应用 Application of puerarin
08/18/2010CN101804029A Atorvastatin liposome and preparation method thereof, and medicine composition containing atorvastatin
08/18/2010CN101804026A Preparation of interferon fat emulsion for injection
08/18/2010CN101803799A Gypenoside-contained cigarette and manufacture method thereof
08/18/2010CN101416944B Sodium ferulic acid nano micelle preparation and preparation method thereof
08/18/2010CN101386592B Method for preparing pitavastatin calcium raw material medicine using asymmetric hydrogenation
08/18/2010CN101284017B A method for continuously preparing birds nest extract with narrow molecular weight distribution by enzymolysis and membrane filtration coupling technique
08/18/2010CN101279034B Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof
08/18/2010CN101254178B Gliclazide controlled release tablets
08/18/2010CN101244201B Chinese medicine composition for treating diabetes and method for preparing the same
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777034 Crystalline ammonium salts of rosuvastatin
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776893 administering N-(3,5-Dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide in a dosage form selected from an oral dosage form, an injectable dosage form, and an infusible dosage form
08/17/2010US7776868 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/17/2010US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776369 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis
08/17/2010US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk
08/17/2010US7776319 Methods and compositions for treatment of ion imbalances
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2557538C Benzimidazole derivative and use as an angiotensin ii receptor antagonist
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2476800C Crystals of glucopyranosyloxybenzyl benzene derivative
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2383814C Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/12/2010WO2010091176A1 Phthalazine-containing antidiabetic compounds
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010090876A2 Satiation peptide administration
08/12/2010WO2010090758A2 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
08/12/2010WO2010090423A2 Composition comprising combined crude drug extract for preventing and treating hyperlipidemia and diabetic hyperlipidemia
08/12/2010WO2010090200A1 Phenylimidazole compounds
08/12/2010WO2010089874A1 Ppar-γ-expression-enhancing agent, adiponectin-production-enhancing agent, ucp-activating agent, and pharmaceutical preparation, food or beverage comprising any one of the agents
08/12/2010WO2010089492A1 Method for coating microspheres onto a flexible material
08/12/2010WO2010089453A1 Animal feed
08/12/2010WO2010089303A1 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
08/12/2010WO2010089221A1 Compositions and methods for inhibiting expression of ptp1b genes
08/12/2010WO2010045529A3 Combination therapies for the treatment of obesity
08/12/2010WO2010045199A3 Method of modulating ship activity
08/12/2010WO2010042868A3 Methods for treating obesity
08/12/2010WO2009152189A8 Low dose topiramate/phentermine compostion and methods of use thereof
08/12/2010WO2009143367A3 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders
08/12/2010WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
08/12/2010WO2009065287A8 Novel mangiferin calcium salts, the method for its preparation and its use
08/12/2010WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
08/12/2010US20100204340 Orally bioavailable stilbenoids- compositions and therapeutic applications thereof
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204278 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
08/12/2010US20100204258 Methods and compositions for modulating insulin secretion and glucose metabolism
08/12/2010US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/12/2010US20100204249 Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia
08/12/2010US20100204240 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
08/12/2010US20100204238 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100204195 Pharmaceutical Compositions and Process for Making Them
08/12/2010US20100204194 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100204179 Resveratrol complex and process for the preperation
08/12/2010US20100204166 Polyacetylenic compounds for stimulating insulin gene exression, production and secretion
1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 1298